| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 10.719.703.412 $ | 99,86 | 481.939.124 | |||||||
| Apogee Therapeutics Inc | Apogee Therapeutics Inc | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 159.763.650 $ | 1,49 | 1.203.674 | |
| Moderna Inc | Moderna Inc | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 151.607.387 $ | 1,41 | 2.164.892 | |
| Twist Bioscience Corp | Twist Bioscience Corp | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 151.142.140 $ | 1,41 | 1.469.111 | |
| Oruka Therapeutics Inc | Oruka Therapeutics Inc | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 147.989.540 $ | 1,38 | 1.555.002 | |
| Kymera Therapeutics Inc | Kymera Therapeutics Inc | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 145.946.701 $ | 1,36 | 1.272.754 | |
| Viking Therapeutics Inc | Viking Therapeutics Inc | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 139.967.802 $ | 1,30 | 3.587.998 | |
| Praxis Precision Medicines Inc | Praxis Precision Medicines Inc | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 138.515.010 $ | 1,29 | 413.737 | |
| Erasca Inc | Erasca Inc | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 136.432.063 $ | 1,27 | 7.447.165 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 129.316.653 $ | 1,20 | 690.499 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals Inc | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 128.980.442 $ | 1,20 | 1.161.672 | |
| CG oncology Inc | CG oncology Inc | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 128.808.819 $ | 1,20 | 1.812.932 | |
| SELLAS Life Sciences Group Inc | SELLAS Life Sciences Group Inc | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 127.743.667 $ | 1,19 | 8.654.720 | |
| Vaxcyte Inc | Vaxcyte Inc | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 127.427.471 $ | 1,19 | 2.192.112 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics Inc | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 127.007.959 $ | 1,18 | 1.302.913 | |
| Cytokinetics Inc | Cytokinetics Inc | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 126.461.659 $ | 1,18 | 1.484.466 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 124.849.899 $ | 1,16 | 459.937 | |
| Scholar Rock Holding Corp | Scholar Rock Holding Corp | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 124.202.980 $ | 1,16 | 2.258.236 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 124.029.493 $ | 1,16 | 3.504.648 | |
| Mirum Pharmaceuticals Inc | Mirum Pharmaceuticals Inc | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 124.001.246 $ | 1,16 | 1.059.206 | |
| Cogent Biosciences Inc | Cogent Biosciences Inc | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 122.794.674 $ | 1,14 | 3.172.989 | |
| Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical Inc | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 122.436.723 $ | 1,14 | 3.666.868 | |
| Travere Therapeutics Inc | Travere Therapeutics Inc | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 121.012.969 $ | 1,13 | 2.130.135 | |
| Alkermes PLC | Alkermes PLC | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 118.998.738 $ | 1,11 | 2.271.185 | |
| Krystal Biotech Inc | Krystal Biotech Inc | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 118.466.467 $ | 1,10 | 318.741 | |
| Celcuity Inc | Celcuity Inc | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 118.046.826 $ | 1,10 | 1.128.339 | |
| Relay Therapeutics Inc | Relay Therapeutics Inc | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 117.960.956 $ | 1,10 | 6.304.701 | |
| Spyre Therapeutics Inc | Spyre Therapeutics Inc | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 117.725.387 $ | 1,10 | 1.326.035 | |
| TG Therapeutics Inc | TG Therapeutics Inc | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 117.336.182 $ | 1,09 | 2.135.715 | |
| Beam Therapeutics Inc | Beam Therapeutics Inc | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 115.873.930 $ | 1,08 | 3.376.280 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 115.546.653 $ | 1,08 | 1.083.724 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 115.392.767 $ | 1,07 | 941.367 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 114.732.416 $ | 1,07 | 1.407.587 | |
| Vera Therapeutics Inc | Vera Therapeutics Inc | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 113.719.524 $ | 1,06 | 2.650.187 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 113.490.387 $ | 1,06 | 228.475 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 113.431.224 $ | 1,06 | 211.251 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 111.376.619 $ | 1,04 | 442.603 | |
| Biogen Inc | Biogen Inc | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 110.742.849 $ | 1,03 | 512.556 | |
| PTC Therapeutics Inc | PTC Therapeutics Inc | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 110.728.502 $ | 1,03 | 1.357.466 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 110.545.261 $ | 1,03 | 1.412.358 | |
| uniQure NV | uniQure NV | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 110.376.388 $ | 1,03 | 2.396.361 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 110.020.441 $ | 1,02 | 1.477.181 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 109.835.924 $ | 1,02 | 2.013.860 | |
| ImmunityBio Inc | ImmunityBio Inc | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 109.402.918 $ | 1,02 | 12.496.050 | |
| Summit Therapeutics Inc | Summit Therapeutics Inc | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 108.592.206 $ | 1,01 | 7.453.137 | |
| Ionis Pharmaceuticals Inc | Ionis Pharmaceuticals Inc | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 107.676.771 $ | 1,00 | 1.358.012 | |
| Incyte Corp | Incyte Corp | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 107.116.358 $ | 1,00 | 944.922 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 106.775.790 $ | 0,99 | 294.863 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 104.317.435 $ | 0,97 | 618.966 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 103.544.853 $ | 0,96 | 819.573 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 103.177.164 $ | 0,96 | 165.470 | |
| Exelixis Inc | Exelixis Inc | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 103.041.549 $ | 0,96 | 1.893.798 | |
| Alnylam Pharmaceuticals Inc | Alnylam Pharmaceuticals Inc | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 102.918.244 $ | 0,96 | 341.887 | |
| BioMarin Pharmaceutical Inc | BioMarin Pharmaceutical Inc | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 101.432.006 $ | 0,94 | 1.772.667 | |
| ACADIA Pharmaceuticals Inc | ACADIA Pharmaceuticals Inc | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 100.622.831 $ | 0,94 | 3.977.187 | |
| Nuvalent Inc | Nuvalent Inc | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 99.692.782 $ | 0,93 | 807.229 | |
| Immunovant Inc | Immunovant Inc | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 99.274.703 $ | 0,92 | 2.576.556 | |
| United Therapeutics Corp | United Therapeutics Corp | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 99.184.691 $ | 0,92 | 183.055 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 97.399.354 $ | 0,91 | 5.756.463 | |
| GRAIL Inc | GRAIL Inc | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 97.321.274 $ | 0,91 | 1.425.535 | |
| BioCryst Pharmaceuticals Inc | BioCryst Pharmaceuticals Inc | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 95.818.290 $ | 0,89 | 9.581.829 | |
| Catalyst Pharmaceuticals Inc | Catalyst Pharmaceuticals Inc | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 93.825.999 $ | 0,87 | 2.985.237 | |
| Dyne Therapeutics Inc | Dyne Therapeutics Inc | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 92.221.650 $ | 0,86 | 4.152.258 | |
| Tango Therapeutics Inc | Tango Therapeutics Inc | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 90.373.942 $ | 0,84 | 2.891.041 | |
| Denali Therapeutics Inc | Denali Therapeutics Inc | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 89.390.297 $ | 0,83 | 3.475.517 | |
| Veracyte Inc | Veracyte Inc | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 87.887.331 $ | 0,82 | 1.496.464 | |
| Ideaya Biosciences Inc | Ideaya Biosciences Inc | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 86.257.725 $ | 0,80 | 2.314.401 | |
| Recursion Pharmaceuticals Inc | Recursion Pharmaceuticals Inc | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 81.244.596 $ | 0,76 | 22.137.492 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 80.161.241 $ | 0,75 | 4.460.837 | |
| Arcus Biosciences Inc | Arcus Biosciences Inc | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 79.781.504 $ | 0,74 | 2.587.788 | |
| Syndax Pharmaceuticals Inc | Syndax Pharmaceuticals Inc | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 77.123.107 $ | 0,72 | 3.528.047 | |
| Arcutis Biotherapeutics Inc | Arcutis Biotherapeutics Inc | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 76.408.462 $ | 0,71 | 2.914.129 | |
| Mineralys Therapeutics Inc | Mineralys Therapeutics Inc | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 76.104.321 $ | 0,71 | 2.820.768 | |
| Celldex Therapeutics Inc | Celldex Therapeutics Inc | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 75.390.697 $ | 0,70 | 2.026.087 | |
| Agios Pharmaceuticals Inc | Agios Pharmaceuticals Inc | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 74.416.720 $ | 0,69 | 2.005.301 | |
| Viridian Therapeutics Inc | Viridian Therapeutics Inc | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 72.076.899 $ | 0,67 | 3.923.620 | |
| Novavax Inc | Novavax Inc | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 70.926.873 $ | 0,66 | 7.529.392 | |
| Disc Medicine Inc | Disc Medicine Inc | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 70.112.077 $ | 0,65 | 958.601 | |
| ADMA Biologics Inc | ADMA Biologics Inc | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 65.228.766 $ | 0,61 | 7.793.162 | |
| Immunome Inc | Immunome Inc | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 63.400.014 $ | 0,59 | 2.991.978 | |
| Palvella Therapeutics Inc | Palvella Therapeutics Inc | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 62.454.172 $ | 0,58 | 408.678 | |
| Iovance Biotherapeutics Inc | Iovance Biotherapeutics Inc | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 60.294.258 $ | 0,56 | 14.493.812 | |
| Absci Corp | Absci Corp | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 59.937.268 $ | 0,56 | 5.171.464 | |
| Nurix Therapeutics Inc | Nurix Therapeutics Inc | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 59.664.583 $ | 0,56 | 2.459.381 | |
| Kodiak Sciences Inc | Kodiak Sciences Inc | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 58.254.784 $ | 0,54 | 1.495.246 | |
| Biohaven Ltd | Biohaven Ltd | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 56.408.012 $ | 0,53 | 3.790.861 | |
| Vericel Corp | Vericel Corp | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 53.134.985 $ | 0,49 | 1.194.313 | |
| AnaptysBio Inc | AnaptysBio Inc | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 53.097.323 $ | 0,49 | 786.627 | |
| Capricor Therapeutics Inc | Capricor Therapeutics Inc | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 52.452.718 $ | 0,49 | 2.178.269 | |
| Stoke Therapeutics Inc | Stoke Therapeutics Inc | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 51.487.701 $ | 0,48 | 1.573.585 | |
| Monte Rosa Therapeutics Inc | Monte Rosa Therapeutics Inc | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 51.152.339 $ | 0,48 | 2.113.733 | |
| Vir Biotechnology Inc | Vir Biotechnology Inc | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 50.394.492 $ | 0,47 | 4.945.485 | |
| Hyperliquid Strategies Inc | Hyperliquid Strategies Inc | EC | 44916Y106 | Long | Börsenkurs (Stufe 1) | 49.813.716 $ | 0,46 | 6.329.570 | |
| Tyra Biosciences Inc | Tyra Biosciences Inc | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 44.472.489 $ | 0,41 | 1.392.376 | |
| Corvus Pharmaceuticals Inc | Corvus Pharmaceuticals Inc | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 43.798.761 $ | 0,41 | 2.931.644 | |
| Cullinan Therapeutics Inc | Cullinan Therapeutics Inc | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 43.296.915 $ | 0,40 | 2.377.645 | |
| Precigen Inc | Precigen Inc | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 40.387.441 $ | 0,38 | 7.085.516 | |
| Inhibrx Biosciences Inc | Inhibrx Biosciences Inc | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 37.997.308 $ | 0,35 | 401.027 | |
| Taysha Gene Therapies Inc | Taysha Gene Therapies Inc | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 37.901.995 $ | 0,35 | 5.565.638 | |
| Ardelyx Inc | Ardelyx Inc | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 37.825.634 $ | 0,35 | 7.416.791 | |
| Avalo Therapeutics Inc | Avalo Therapeutics Inc | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 37.505.012 $ | 0,35 | 2.029.492 | |
| MannKind Corp | MannKind Corp | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 36.286.454 $ | 0,34 | 8.517.947 | |
| Annexon Inc | Annexon Inc | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 35.595.312 $ | 0,33 | 6.233.855 | |
| ORIC Pharmaceuticals Inc | ORIC Pharmaceuticals Inc | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 35.363.026 $ | 0,33 | 3.265.284 | |
| Zenas Biopharma Inc | Zenas Biopharma Inc | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 34.247.670 $ | 0,32 | 1.349.396 | |
| Jade Biosciences Inc | Jade Biosciences Inc | EC | 008064206 | Long | Börsenkurs (Stufe 1) | 34.075.992 $ | 0,32 | 1.533.573 | |
| Kura Oncology Inc | Kura Oncology Inc | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 34.070.045 $ | 0,32 | 3.105.747 | |
| Olema Pharmaceuticals Inc | Olema Pharmaceuticals Inc | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 33.989.082 $ | 0,32 | 2.716.953 | |
| CareDx Inc | CareDx Inc | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 32.585.675 $ | 0,30 | 1.143.357 | |
| Bicara Therapeutics Inc | Bicara Therapeutics Inc | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 32.556.362 $ | 0,30 | 1.096.543 | |
| Vor BioPharma Inc | Vor BioPharma Inc | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 32.333.354 $ | 0,30 | 1.756.293 | |
| Xencor Inc | Xencor Inc | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 31.228.687 $ | 0,29 | 1.939.670 | |
| ArriVent Biopharma Inc | ArriVent Biopharma Inc | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 30.585.999 $ | 0,28 | 880.426 | |
| Replimune Group Inc | Replimune Group Inc | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 30.492.226 $ | 0,28 | 2.754.492 | |
| CytomX Therapeutics Inc | CytomX Therapeutics Inc | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 29.865.784 $ | 0,28 | 7.964.209 | |
| Janux Therapeutics Inc | Janux Therapeutics Inc | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 29.621.622 $ | 0,28 | 1.928.491 | |
| Sionna Therapeutics Inc | Sionna Therapeutics Inc | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 28.492.059 $ | 0,27 | 647.694 | |
| Geron Corp | Geron Corp | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 27.925.743 $ | 0,26 | 21.816.987 | |
| Solid Biosciences Inc | Solid Biosciences Inc | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 25.796.867 $ | 0,24 | 2.582.269 | |
| Rigel Pharmaceuticals Inc | Rigel Pharmaceuticals Inc | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 25.440.949 $ | 0,24 | 650.331 | |
| Allogene Therapeutics Inc | Allogene Therapeutics Inc | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 25.257.436 $ | 0,24 | 12.142.998 | |
| Sana Biotechnology Inc | Sana Biotechnology Inc | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 24.700.534 $ | 0,23 | 7.077.517 | |
| Altimmune Inc | Altimmune Inc | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 24.614.041 $ | 0,23 | 8.096.724 | |
| REGENXBIO Inc | REGENXBIO Inc | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 23.468.532 $ | 0,22 | 1.958.976 | |
| Ironwood Pharmaceuticals Inc | Ironwood Pharmaceuticals Inc | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 23.154.322 $ | 0,22 | 5.499.839 | |
| Immix Biopharma Inc | Immix Biopharma Inc | EC | 45258H106 | Long | Börsenkurs (Stufe 1) | 21.692.601 $ | 0,20 | 2.104.035 | |
| Ocugen Inc | Ocugen Inc | EC | 67577C105 | Long | Börsenkurs (Stufe 1) | 21.399.220 $ | 0,20 | 13.986.418 | |
| 4D Molecular Therapeutics Inc | 4D Molecular Therapeutics Inc | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 21.394.633 $ | 0,20 | 1.608.619 | |
| Candel Therapeutics Inc | Candel Therapeutics Inc | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 20.847.602 $ | 0,19 | 2.024.039 | |
| Savara Inc | Savara Inc | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 19.688.093 $ | 0,18 | 3.196.119 | |
| Prime Medicine Inc | Prime Medicine Inc | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 19.285.110 $ | 0,18 | 5.226.317 | |
| First Tracks Biotherapeutics Inc | First Tracks Biotherapeutics Inc | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 18.718.702 $ | 0,17 | 930.353 | |
| Damora Therapeutics Inc | Damora Therapeutics Inc | EC | 36322Q206 | Long | Börsenkurs (Stufe 1) | 18.595.355 $ | 0,17 | 714.931 | |
| ARS Pharmaceuticals Inc | ARS Pharmaceuticals Inc | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 18.319.198 $ | 0,17 | 2.287.041 | |
| MapLight Therapeutics Inc | MapLight Therapeutics Inc | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 17.863.660 $ | 0,17 | 498.428 | |
| Arbutus Biopharma Corp | Arbutus Biopharma Corp | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 17.643.494 $ | 0,16 | 3.675.728 | |
| Myriad Genetics Inc | Myriad Genetics Inc | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 17.218.385 $ | 0,16 | 3.015.479 | |
| Cabaletta Bio Inc | Cabaletta Bio Inc | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 16.346.860 $ | 0,15 | 5.256.225 | |
| Compass Therapeutics Inc | Compass Therapeutics Inc | EC | 20454B104 | Long | Börsenkurs (Stufe 1) | 14.979.221 $ | 0,14 | 6.839.827 | |
| Emergent BioSolutions Inc | Emergent BioSolutions Inc | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 14.298.274 $ | 0,13 | 1.706.238 | |
| Prothena Corp PLC | Prothena Corp PLC | EC | IE00B91XRN20 | Long | Börsenkurs (Stufe 1) | 14.228.835 $ | 0,13 | 1.453.405 | |
| Vanda Pharmaceuticals Inc | Vanda Pharmaceuticals Inc | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 14.025.198 $ | 0,13 | 2.291.699 | |
| Perspective Therapeutics Inc | Perspective Therapeutics Inc | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 13.763.718 $ | 0,13 | 4.036.281 | |
| Ovid therapeutics Inc | Ovid therapeutics Inc | EC | 690469101 | Long | Börsenkurs (Stufe 1) | 13.236.191 $ | 0,12 | 4.920.517 | |
| Verastem Inc | Verastem Inc | EC | 92337C203 | Long | Börsenkurs (Stufe 1) | 12.946.412 $ | 0,12 | 3.389.113 | |
| MiMedx Group Inc | MiMedx Group Inc | EC | 602496101 | Long | Börsenkurs (Stufe 1) | 11.383.734 $ | 0,11 | 2.956.814 | |
| Lexeo Therapeutics Inc | Lexeo Therapeutics Inc | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 11.309.751 $ | 0,11 | 2.429.592 | |
| Achieve Life Sciences Inc | Achieve Life Sciences Inc | EC | 004468500 | Long | Börsenkurs (Stufe 1) | 8.814.573 $ | 0,08 | 1.349.858 | |
| Sagimet Biosciences Inc | Sagimet Biosciences Inc | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 7.599.726 $ | 0,07 | 983.147 | |
| BridgeBio Oncology Therapeutics Inc | BridgeBio Oncology Therapeutics Inc | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 6.197.354 $ | 0,06 | 813.301 | |
| Atrium Therapeutics Inc | Atrium Therapeutics Inc | EC | 04965N104 | Long | Börsenkurs (Stufe 1) | 7 $ | 0,00 | 1 | |
| OMNIAB INC | OMNIAB INC | EC | 68218J301 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 323.918 | |
| 10.719.703.412 $ | 99,86 | 481.939.124 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.